CDC advisors broaden RSV vaccine recommendations to at-risk adults in their 50s

A CDC advisory panel voted to recommend RSV vaccines for at-risk adults aged 50 to 59, a sought-after expansion by vaccine makers who are trying to grow the market. The vote from the Advisory Committee ...